Axis of evil: molecular mechanisms of cancer metastasis von Bogenrieder, Thomas, Herlyn, Meenhard

Volltext

Topotecan in cervical cancer von ACKERMANN, S., BECKMANN, M. W., THIEL, F., BOGENRIEDER, T.

Volltext

Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II von Vogt, T, McClelland, M, Jung, B, Popova, S, Bogenrieder, T, Becker, B, Rumpler, G, Landthaler, M, Stolz, W

Volltext

SO-11 KISIMA-01 trial: Safety, tolerability and immunogenicity of ATP128 with or without ezabenlimab (BI 754091) in patients with stage IV colorectal cancer – preliminary results f... von Kopetz, S., Prenen, H., Sharma, S., Van Cutsem, E., Mayol, J., Trapani, F., Bogenrieder, T., Lenz, H.

Volltext

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic bre... von Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier

Volltext

Orofacial granulomatosis as initial manifestation of Crohn's disease: a report of two cases von Girlich, C, Bogenrieder, T, Palitzsch, K.-D, Schölmerich, J, Lock, G

Volltext

Benign Degos' disease developing during pregnancy and followed for 10 years von BOGENRIEDER, Thomas, KUSKE, Marion, LANDTHALER, Michael, STOLZ, Wilhelm

Volltext

Melanoma–stroma interactions: structural and functional aspects von Ruiter, Dirk, Bogenrieder, Thomas, Elder, David, Herlyn, Meenhard

Volltext

A Phase Ib trial of xentuzumab and abemaciclib in patients with locally advanced or metastatic solid tumours, hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer (... von Prat, A., Yee, D., Sablin, M.P., Iwata, H., Johnston, E.L., Bogenrieder, T., Serra, J., Stucke-Straub, K., Lo Russo, P.

Volltext

Pilot Study on the Feasibility, Safety and Immunogenicity of a Personalized Neoantigen-Targeted Immunotherapy (NeoPepVac) in Combination with Anti-PD-1 or Anti-PD-L1 in Advanced So... von Moerk, S.K., Donia, M., Kringelum, J.V., Bogenrieder, T., Rønø, B., Sorensen, A.B., Draghi, A., Bol, K.F., Petersen, N.V., Kadivar, M., Hernandez, S.S., Hadrup, S. Reker, Andreasen, L.V., Christensen, D., Andersen, P.L., Svane, I.M.

Volltext

Abstract OT3-06-02: A phase Ib trial of xentuzumab and abemaciclib in patients with locally advanced or metastatic solid tumors, including hormone receptor-positive, HER2-negative... von Yee, D, Sablin, MP, Iwata, H, Johnston, EL, Bogenrieder, T, Serra, J, Hua, H, Lo Russo, P, Prat, A

Volltext

Wells’ syndrome associated with idiopathic hypereosinophilic syndrome von BOGENRIEDER, T., GRIESE, D.P., SCHIFFNER, R., BÜTTNER, R., RIEGGER, G.A.J., HOHENLEUTNER, U., LANDTHALER, M.

Volltext

A phase Ib trial of xentuzumab and abemaciclib in patients with locally advanced or metastatic solid tumors, hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer (B... von Yee, D., Prat, A., Sablin, M.P., Iwata, H., Johnston, E.L., Bogenrieder, T., Serra, J., Hua, H., LoRusso, P.

Volltext

479TiP Phase Ib trial of afatinib and BI 836845 in advanced non-small cell lung cancer (NSCLC) von Tan, D., Lin, C.-C., Chin-Lun Huang, D., Jung, H., Bogenrieder, T., Park, K.

Volltext

Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications von Papay, Julie, Yuen, Nancy, Powell, Greg, Mockenhaupt, Maja, Bogenrieder, Thomas

Volltext

Abstract P6-21-01: Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR+... von Crown, J, Sablin, M-P, Cortés, J, Bergh, J, Im, S-A, Lu, Y-S, Martínez, N, Neven, P, Lee, KS, Morales, S, Pérez-Fidalgo, JA, Adamson, D, Goncalves, A, Prat, A, Jerusalem, G, Schlieker, L, Espadero, R-M, Bogenrieder, T, Chin-Lun Huang, D, Schmid, P

Volltext

Phase I dose escalation (esc) trial of weekly intravenous (i.v.) BI 836845 in Japanese patients (pts) with advanced solid tumors von Doi, T., Shitara, K., Naito, Y., Kuboki, Y., Kojima, T., Hosono, A., Yoshino, T., Kawamoto, H., Tadayasu, Y., Ugai, H., Takeuchi, Y., Bogenrieder, T., Yoh, K.

Volltext

Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil von Li, Gang, Satyamoorthy, Kapaettu, Meier, Friedegund, Berking, Carola, Bogenrieder, Thomas, Herlyn, Meenhard

Volltext

Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid von HOFFMAN, A. D, ENGELSTEIN, D, BOGENRIEDER, T, PAPANDREOU, C. N, STECKELMAN, E, DAVE, A, MOTZER, R. J, DMITROVSKY, E, ALBINO, A. P, NANUS, D. M

Volltext

The genre of corporate history von Delahaye, Agnès, Booth, Charles, Clark, Peter, Procter, Stephen, Rowlinson, Michael

Volltext